ClinicalTrials.gov
public full text
Public Domain
Celecoxib in Treating Patients With Bladder Cancer
This randomized phase IIb/III trial is studying celecoxib to see how well it works in preventing disease recurrence in patients who have bladder cancer. Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of celecoxib may be an effective way to prevent the recurrence of bladder cancer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer#1260870
- Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps#1032306
- A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer#1307786
- Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma#1032450
- Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)#891657
Record · ID 1194988
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive